Sagent Pharmaceuticals (SGNT)
Create an AlertSGNT Key Stats
| Income Statement | |
| Revenue TTM | 205.55M |
| Revenue Quarterly YoY Growth | 57.29% |
| EPS Diluted TTM | 0.0378 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | 1.31M |
| Profitability | |
| Gross Profit Margin Quarterly | 30.66% |
| Profit Margin Quarterly | 16.34% |
| Dividend | |
| Dividend Yield | 0% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 554.95M |
| Enterprise Value | 483.69M |
| PE Ratio TTM | 521.79 |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 3.856 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow | 6.707M |
| Return on Equity | 0.97% |
SGNT News
- SAGENT PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote... Jun 14
- This Metric Says You're Smart to Own Sagent Pharmaceuticals Fool Jun 14
- Sagent Pharma (SGNT) Expands Recall Street Insider Jun 13
- InPlay: Sagent Pharma expands a nationwide voluntary recall to all lots of Vecur... Jun 13
- Sagent Pharmaceuticals Expands a Nationwide Voluntary Recall to All Lots of Vecu... Jun 13
- Sagent Recalls Anesthesia Drug Dosages Fool Jun 9
- 4 Healthcare Stock Stories As a Weekend Investment Prescription Jun 7
- Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Three Lots of ... Jun 7
- Sagent Pharmaceuticals Stays On Its Margin Hot Streak Fool Jun 6
- China Biotech In Review: Sagent Buys Out China JV Partner For $25 Million May 12
SGNT Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Sagent Pharmaceuticals is up 5.29% over the last year vs S&P 500 Total Return up 23.89%, Acura Pharmaceuticals down 34.41%, and ImmunoBiotics down 44.00%.
SGNT Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these SGNT related companies
Pro Ratings for SGNT
Pro Report PDF for SGNT
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download SGNT Pro Report PDF
Pro Strategies Featuring SGNT
Did Sagent Pharmaceuticals make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
SGNT Profile
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Other SGNT Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| SGNT | 19.67 | -0.04 | -0.20% | 554.95M |
